All part of putting the "5 path” plan into action. The appointment of Dr Messina allows us to accelerate the Australian arm of the 5 path strategy.
Some of you might be wondering about the wisdom of hiring someone from Noxopharma (I won’t say too much on this topic), but Marinella was not responsible for the corporate or clinical strategy at NOX. Dr Messina brings us an impressive skill set of being able to get trials done with limited resources. Borje, me and the scientific advisor board are responsible for setting the goals and KPI and Marinella is responsible for turning these into reality on the ground. I have no doubt she will prove to be a very valuable asset for RAC and I am really looking forward to working closely with her.
Ann: Race appoints Australian Clinical Program Director, page-3
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.57 |
Change
-0.045(2.80%) |
Mkt cap ! $260.3M | |||
| Open | High | Low | Value | Volume |
| $1.60 | $1.60 | $1.55 | $94.33K | 60.12K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1250 | $1.57 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.59 | 5000 | 1 |
View Market Depth
| Last trade - 14.37pm 16/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.56 |
Change
-0.045 ( 1.17 %) |
||||
| Open | High | Low | Volume | ||
| $1.58 | $1.59 | $1.55 | 8174 | ||
| Last updated 14.21pm 16/05/2024 ? | |||||
| RAC (ASX) Chart |